| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.071 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |